Meridian Clinical Research logo in white.

Meningococcal Vaccine Study

 Study Now Open in Omaha, NE

Invasive meningococcal disease (IMD) is a serious illness with symptoms that may include intense headache, fever, nausea, vomiting, stiff neck, and lethargy. At least 12 different meningococcal serogroups have been classified. Outbreaks of meningococcal disease have also been reported on college campuses in the US. Meningococcal disease can lead to meningitis, which is an infection of the lining of the brain and spinal cord.

Eligible participants…

  • Must be age 19 to 25
  • Must not have received a meningococcal serogroup B vaccine
  • May receive compensation for time and travel
  • May get study-related care at no cost
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.

Study Location

Meridian Clinical Research
3319 N 107th St
Omaha, NE 68134

Submit Your Information

Meridian Clinical Research logo in white.

About Meridian Clinical Research

Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.

Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.